Meta-analysis · people

Ecnoglutide lowered HbA1c and weight in type 2 diabetes: meta-analysis

Checked against the paper Meta-analysisPublished by PepVault

The takeaway

In pooled trials of adults with type 2 diabetes, ecnoglutide lowered blood sugar and weight versus controls, with more side effects that were mostly mild gut symptoms and no significant rise in serious ones.

Kind
Meta-analysis
Studied in
People
Number studied
1643
Published
2026
Journal
Endocrinol Diabetes Metab

What they tested

The team wanted to know how well ecnoglutide works and how safe it is for adults with type 2 diabetes when the randomized trials are pooled together.

How the study was done

A systematic review and meta-analysis that pooled a small set of randomized controlled trials with 1643 adults with type 2 diabetes. The trials compared ecnoglutide (1162 people) with placebo, a dummy treatment, or another active drug (444 people).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

Model. Individual results vary.

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Compared with control groups, ecnoglutide lowered HbA1c, a long-term average of blood sugar, with a mean difference of -0.44 (95% CI -0.55 to -0.33). Body weight fell with a mean difference of -5.63 (95% CI -7.90 to -3.35), and fasting blood sugar fell with a mean difference of -0.81 (95% CI -1.03 to -0.59). Insulin sensitivity, blood fats and liver enzymes also improved. Side effects were more common with ecnoglutide (risk ratio 1.09), mostly gut-related and mild to moderate, and serious side effects did not differ significantly between groups.

What it doesn’t show

The analysis pools only a handful of trials and mixes placebo and active-drug comparisons, so it can't say how ecnoglutide compares with any single drug. It covers adults with type 2 diabetes only, not people with obesity who don't have diabetes.

The paper

Kumar et al. Comparative Efficacy and Safety of Ecnoglutide in Type 2 Diabetes: A Systematic Review and Meta-Analysis. Endocrinol Diabetes Metab. 2026.

The compound

More studies on Ecnoglutide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking ecnoglutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo